Abbott Laboratories (ABT)

$84.47 -0.43 (-0.51%)
Market Cap 147.88B
Revenue (ttm) 44.33B
Net Income (ttm) 6.52B
EPS (ttm) N/A
PE Ratio 16.09
Forward PE 15.31
Profit Margin 14.72%
Debt to Equity Ratio 0.65
Volume 13,208,500
Avg Vol 13,125,554
Day's Range N/A - N/A
Shares Out 1.74B
Stochastic %K 39%
Beta 0.65
Analysts Strong Sell
Price Target $119.00

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices
Sector: Healthcare
Phone: 224 667 6100
Address:
100 Abbott Park Road, Abbott Park, United States
Abushawar
Abushawar May. 16 at 9:50 AM
$ABT
0 · Reply
1212JM
1212JM May. 15 at 9:26 PM
$ABT oil prices thru the roof, inflation rising, recession risk increasing more and more each day, and speculative markets like crypto and AI hitting ATHs… while blue chip cash cows are down 30% or more because of peoples FOMO in AI trade…. What could go wrong 🥴 great buy here.
0 · Reply
Loudermilk64
Loudermilk64 May. 15 at 7:55 PM
$ABT Cologuard Baby!
0 · Reply
1212JM
1212JM May. 15 at 7:20 PM
$ABT we are living in repeat of 1999. I hope this continues to trade here for a couple of months before the tech thing blows up in everyone’s faces. I want time to continue to accumulate. Hands down one of the best compounding companies in American history.
2 · Reply
Probably_Drunk
Probably_Drunk May. 15 at 6:29 PM
$ABT Keep getting a tiny bit of optimism, and then immediately punched in the dick. Thanks
0 · Reply
Suite510
Suite510 May. 15 at 4:29 PM
$ABT $JNJ $KVUE $SPX JNJ is a ticking bomb, 30B to 50B talc liability upcoming, there getting slammed in LA Court this week 😂 66,000 plaintiffs will finally get there justice after years of delays May 14, 2026 Human Reproduction Proves Talc Can Reach Ovaries, Jury Told A medical oncologist on Thursday told a Los Angeles bellwether jury considering claims that Johnson & Johnson's talc products caused three women's deadly ovarian cancer that the female reproductive system is an "open" system where talc can migrate to the ovaries, and that "we wouldn't exist" if that was not!
0 · Reply
jewell69
jewell69 May. 15 at 3:30 PM
up until this morning 5/15, I saw a nice base building trend that has turned to a (hopefully) up trend in $IHI I've been losing / underperforming on this and #2 holding $ABT (15.76% of this portfolio) and $BSX #10 holding 4.08% of portfolio ) I'm selling these today because "I can" and will buy high risk stuff like $IYW on a buy on the dip mentality. then I can always get back to these IHIs as I get out of the high risk stuff that I am about to buy.
1 · Reply
Togdjclecj
Togdjclecj May. 15 at 2:46 PM
$ABT $BSX pretty much exact same chart today. Hold and wait for the powers that be to let us loose.
0 · Reply
Wallstfan
Wallstfan May. 15 at 2:12 PM
$ABT being so manipulated right now. We should be over $90
0 · Reply
Loudermilk64
Loudermilk64 May. 15 at 1:27 PM
$ABT
0 · Reply
Latest News on ABT
Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

May 15, 2026, 1:00 AM EDT - 1 day ago

Even a High-Priced Market Has Bargains. 10 Undervalued Blue-Chip Stocks.

ACN DHR HD MCD MDT MKC RSG

3 ‘Strong Buy’ Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26

2026-05-14T20:15:24.000Z - 2 days ago

3 ‘Strong Buy’ Dividend Aristocrat Stocks with 100%+ Payout Ratios, 5/14/26

ABBV NEE

Jefferies medical supplies analyst holds analyst/industry conference call

2026-05-07T22:44:28.000Z - 8 days ago

Jefferies medical supplies analyst holds analyst/industry conference call

Abbott removed from US Conviction List at Goldman Sachs

2026-05-01T09:21:21.000Z - 15 days ago

Abbott removed from US Conviction List at Goldman Sachs

Abbott receives FDA clearance and CE Mark for Ultreon imaging platform

2026-04-28T13:41:07.000Z - 18 days ago

Abbott receives FDA clearance and CE Mark for Ultreon imaging platform

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Apr 28, 2026, 9:00 AM EDT - 18 days ago

Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

Apr 25, 2026, 12:30 PM EDT - 21 days ago

Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Apr 17, 2026, 3:30 PM EDT - 4 weeks ago

New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Apr 16, 2026, 11:22 AM EDT - 4 weeks ago

Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales

Abbott Laboratories Earnings Call Transcript: Q1 2026

Apr 16, 2026, 9:00 AM EDT - 4 weeks ago

Abbott Laboratories Earnings Call Transcript: Q1 2026

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Apr 16, 2026, 8:05 AM EDT - 4 weeks ago

Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Are Biting.

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Apr 16, 2026, 7:33 AM EDT - 4 weeks ago

Abbott first-quarter results beat on cancer diagnostics, medical device strength

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Apr 16, 2026, 7:30 AM EDT - 4 weeks ago

Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

Apr 9, 2026, 10:16 PM EDT - 5 weeks ago

Jury orders Abbott to pay $53 million in preterm infant formula trial, media report says

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Apr 9, 2026, 9:00 AM EDT - 5 weeks ago

New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Mar 30, 2026, 9:00 AM EDT - 6 weeks ago

Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform

Abbott hosts conference call for first-quarter earnings

Mar 26, 2026, 9:00 AM EDT - 7 weeks ago

Abbott hosts conference call for first-quarter earnings

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Mar 24, 2026, 8:00 AM EDT - 7 weeks ago

John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening

Abbott completes acquisition of Exact Sciences

Mar 23, 2026, 8:50 AM EDT - 7 weeks ago

Abbott completes acquisition of Exact Sciences

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Mar 20, 2026, 9:00 AM EDT - 2 months ago

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Mar 13, 2026, 2:17 PM EDT - 2 months ago

Pivot Bio CEO Chris Abbott to Present at World Agri-Tech Innovation Summit

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management

Exact Sciences Stockholders Approve Acquisition by Abbott

Feb 20, 2026, 4:05 PM EST - 3 months ago

Exact Sciences Stockholders Approve Acquisition by Abbott

EXAS

Abbott declares 409th consecutive quarterly dividend

Feb 20, 2026, 11:38 AM EST - 3 months ago

Abbott declares 409th consecutive quarterly dividend

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

Feb 17, 2026, 11:32 AM EST - 3 months ago

Carl Abbott's “House of Columns” Brings Sarasota School Modernism to the Market on Longboat Key

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 3 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ADBE AMGN AVGO BAC BK BMY

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Feb 6, 2026, 8:00 AM EST - 3 months ago

Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Feb 4, 2026, 10:49 AM EST - 3 months ago

Abbott recalls glucose sensors after seven deaths linked to faulty readings

Is The Fall In Abbott Stock Justified?

Jan 23, 2026, 9:35 AM EST - 4 months ago

Is The Fall In Abbott Stock Justified?

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Jan 23, 2026, 6:43 AM EST - 4 months ago

Abbott faces India scrutiny in cough syrup abuse investigation, documents show

Abbott Laboratories Raised Prices, Prompting Sales Slump

Jan 22, 2026, 2:31 PM EST - 4 months ago

Abbott Laboratories Raised Prices, Prompting Sales Slump

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

Jan 22, 2026, 11:00 AM EST - 4 months ago

MRNA Rallies on Cancer Vaccine Trial, PG Mixed Earnings, ABT Sell-Off

MRNA PG

Cramer's Mad Dash: Abbott Labs

Jan 22, 2026, 9:53 AM EST - 4 months ago

Cramer's Mad Dash: Abbott Labs

Abbott Laboratories Earnings Call Transcript: Q4 2025

Jan 22, 2026, 9:00 AM EST - 4 months ago

Abbott Laboratories Earnings Call Transcript: Q4 2025

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Jan 22, 2026, 7:49 AM EST - 4 months ago

Abbott Stock Slumps on Earnings. What's Weighing on the Medical Devices Maker.

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Jan 22, 2026, 7:34 AM EST - 4 months ago

Abbott misses quarterly revenue estimates on weakness in diagnostics segment

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Jan 22, 2026, 7:30 AM EST - 4 months ago

Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Jan 20, 2026, 9:00 AM EST - 4 months ago

Abbott receives CE Mark for the TactiFlex™ Duo Ablation Catheter to treat patients with abnormal heart rhythms

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Jan 7, 2026, 8:00 AM EST - 4 months ago

Sentinel Opportunity Fund I Closes Seventh and Eighth Acquisitions with Abbott Laboratories and V3 Engineering, Advancing a Diversified Portfolio Strategy

Abbott hosts conference call for fourth-quarter earnings

Jan 5, 2026, 4:30 PM EST - 4 months ago

Abbott hosts conference call for fourth-quarter earnings

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Jan 5, 2026, 9:05 AM EST - 4 months ago

Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Dec 22, 2025, 9:00 AM EST - 5 months ago

Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Dec 18, 2025, 9:00 AM EST - 5 months ago

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

Abbott increases quarterly dividend for 54th consecutive year

Dec 12, 2025, 10:26 AM EST - 5 months ago

Abbott increases quarterly dividend for 54th consecutive year

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

Dec 8, 2025, 9:00 AM EST - 5 months ago

Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Dec 6, 2025, 8:45 PM EST - 5 months ago

University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Dec 4, 2025, 11:00 AM EST - 5 months ago

Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement

Abbott issues US device correction for some glucose monitors over faulty readings risk

Nov 24, 2025, 11:08 AM EST - 6 months ago

Abbott issues US device correction for some glucose monitors over faulty readings risk

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

Nov 21, 2025, 8:30 PM EST - 6 months ago

Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS

EXAS

Abbott Laboratories Transcript: M&A Announcement

Nov 20, 2025, 9:00 AM EST - 6 months ago

Abbott Laboratories Transcript: M&A Announcement

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Nov 20, 2025, 8:43 AM EST - 6 months ago

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

EXAS

Abbott to Acquire Exact Sciences for $21 Billion

Nov 20, 2025, 7:46 AM EST - 6 months ago

Abbott to Acquire Exact Sciences for $21 Billion

EXAS

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

Nov 20, 2025, 7:46 AM EST - 6 months ago

Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.

EXAS

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

Nov 20, 2025, 7:36 AM EST - 6 months ago

Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences

EXAS

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

Nov 20, 2025, 7:30 AM EST - 6 months ago

Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

EXAS

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

Nov 19, 2025, 4:27 PM EST - 6 months ago

Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories

EXAS

Abushawar
Abushawar May. 16 at 9:50 AM
$ABT
0 · Reply
1212JM
1212JM May. 15 at 9:26 PM
$ABT oil prices thru the roof, inflation rising, recession risk increasing more and more each day, and speculative markets like crypto and AI hitting ATHs… while blue chip cash cows are down 30% or more because of peoples FOMO in AI trade…. What could go wrong 🥴 great buy here.
0 · Reply
Loudermilk64
Loudermilk64 May. 15 at 7:55 PM
$ABT Cologuard Baby!
0 · Reply
1212JM
1212JM May. 15 at 7:20 PM
$ABT we are living in repeat of 1999. I hope this continues to trade here for a couple of months before the tech thing blows up in everyone’s faces. I want time to continue to accumulate. Hands down one of the best compounding companies in American history.
2 · Reply
Probably_Drunk
Probably_Drunk May. 15 at 6:29 PM
$ABT Keep getting a tiny bit of optimism, and then immediately punched in the dick. Thanks
0 · Reply
Suite510
Suite510 May. 15 at 4:29 PM
$ABT $JNJ $KVUE $SPX JNJ is a ticking bomb, 30B to 50B talc liability upcoming, there getting slammed in LA Court this week 😂 66,000 plaintiffs will finally get there justice after years of delays May 14, 2026 Human Reproduction Proves Talc Can Reach Ovaries, Jury Told A medical oncologist on Thursday told a Los Angeles bellwether jury considering claims that Johnson & Johnson's talc products caused three women's deadly ovarian cancer that the female reproductive system is an "open" system where talc can migrate to the ovaries, and that "we wouldn't exist" if that was not!
0 · Reply
jewell69
jewell69 May. 15 at 3:30 PM
up until this morning 5/15, I saw a nice base building trend that has turned to a (hopefully) up trend in $IHI I've been losing / underperforming on this and #2 holding $ABT (15.76% of this portfolio) and $BSX #10 holding 4.08% of portfolio ) I'm selling these today because "I can" and will buy high risk stuff like $IYW on a buy on the dip mentality. then I can always get back to these IHIs as I get out of the high risk stuff that I am about to buy.
1 · Reply
Togdjclecj
Togdjclecj May. 15 at 2:46 PM
$ABT $BSX pretty much exact same chart today. Hold and wait for the powers that be to let us loose.
0 · Reply
Wallstfan
Wallstfan May. 15 at 2:12 PM
$ABT being so manipulated right now. We should be over $90
0 · Reply
Loudermilk64
Loudermilk64 May. 15 at 1:27 PM
$ABT
0 · Reply
randallthedane
randallthedane May. 15 at 1:08 PM
$ABT I’ve been accumulating shares down here. At some point I think the market rotation out of crowded tech and into beaten-down healthcare names starts to happen, and Abbott feels well positioned for that shift. I’m also bullish long term on the Exact Sciences acquisition opportunity and Abbott’s expanding presence in cardiac care. The arrhythmia monitoring market is only getting bigger as AFib and other rhythm disorders are diagnosed more frequently across an aging population which of course in many cases translates into procedures.
0 · Reply
Pharmer23
Pharmer23 May. 15 at 12:23 PM
$BSX perhaps today is the start of a full blown reversal . $ABT
1 · Reply
StockProTrader4
StockProTrader4 May. 14 at 10:51 PM
$DJI Look BELOW Folks! Dont miss out and have to chase later. Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post …
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 10:50 PM
$SPY Look BELOW Folks! Dont miss out and have to chase later…. Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post 👍🏾!!!
0 · Reply
happy_Wojak
happy_Wojak May. 14 at 7:31 PM
$ABT where is our wolf of wall street @Bstell ?
0 · Reply
cea
cea May. 14 at 7:27 PM
$ABT $HD $MCD $SLS $SYK @Stocktwits Reporting @StockProTrader4 for mass spamming unrelated content to multiple boards. BLOCKED.
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 7:00 PM
$SLS Look BELOW Folks! Dont miss out and have to chase later… Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 5:35 PM
$TSLA Look BELOW Folks! Dont miss out and have to chase later when they’re moving up…. Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 5:35 PM
$NVDA Look BELOW Folks! Dont miss out and have to chase later when they move! Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 5:34 PM
$NFLX Look BELOW Folks! Dont miss out and have to chase later…. Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post !!!
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 5:33 PM
$QQQ Look BELOW Folks! Dont miss out and have to chase later. Get in now! Come back and thank me later!!! $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post 👍🏾
0 · Reply
StockProTrader4
StockProTrader4 May. 14 at 5:32 PM
$DIS Look BELOW Folks! Dont miss out and have to chase later! Get in now! Come back and thank me later! 👌🏾 $MCD Beat Earnings near all time low $SYK Analysts Signal Buy $HD Reversal incoming $ABT Near record Low - Reversal Coming These will be the next runners!💥🔥📈Tag this post
0 · Reply